1. Centers for Disease Control and Prevention. Sexually Transmitted Infections (STIs). Available at https://www.cdc.gov/std/statistics/2022/default.htm. Last accessed September 11, 2024.
2. Medline Plus. Reportable Diseases. Available at https://medlineplus.gov/ency/article/001929.htm. Last accessed September 10, 2024..
3. Centers for Disease Control and Prevention. Sexually Transmitted Infections Surveillance, 2022. Available at https://www.cdc.gov/std/statistics/2022/overview.htm. Last accessed September 11, 2024.
4. Canto SVE, Araújo MAL, Miranda AE, Cardoso ARP, de Almeida RLF. Fetal and infant mortality of congenital syphilis reported to the Health Information System. PLoS One. 2019;14(1):e0209906.
5. Centers for Disease Control and Prevention. CDC Estimates 1 in 5 People in the U.S. Have a Sexually Transmitted Infection. Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/media/releases/2021/p0125-sexualy-transmitted-infection.html. Last accessed September 24, 2024.
6. National Academies of Sciences, Engineering, and Medicine. Sexually Transmitted Infections: Adopting a Sexual Health Paradigm. Washington, DC: The National Academies Press; 2021. Available at https://nap.nationalacademies.org/read/25955/chapter/1. Last accessed September 25, 2024.
7. Centers for Disease Control and Prevention. About Gonorrhea. Available at https://www.cdc.gov/gonorrhea/about. Last accessed September 12, 2024.
8. Frank KM, McAdam AJ. Infectious diseases. In: Kumar V, Abbas AK, Aster JC (eds). Robbins and Cotran Pathologic Basis of Disease. 10th ed. Philadelphia, PA: Elsevier Saunders; 2020.
9. Quillin S, Seifert H. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat Rev Microbiol. 2018;16:226-240.
10. Marrazzo JM, Handsfield HH, Sparling PF. Neisseria gonorrhea. In: Mandel GL, Gordon Douglas R, Bennett JE (eds). Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010.
11. Centers for Disease Control and Prevention. Gonococcal Infections Among Adolescents and Adults. Available at https://www.cdc.gov/std/treatment-guidelines/gonorrhea-adults.htm. Last accessed September 12, 2024.
12. Tyring SK (ed). Mucosal Immunology and Virology. Singapore: Springer-Verlag London Limited; 2006.
13. Dodd CL, Greenspan D, Greenspan JS. Oral Kaposi's sarcoma in a woman as a first indication of HIV infection. J Am Dent Assoc. 1991;122(4):61-63.
14. Mayor MT, Roett MA, Uduhiri KA. Diagnosis and management of gonococcal infections. Am Fam Physician. 2012;86(10):931-938.
15. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR. 2021;70(RR4):1-187.
16. Miller KE. Diagnosis and treatment of Neisseria gonorrhoeae infections. Am Fam Physician. 2006;73(10):1779-1784.
17. Yonke N, Aragón M, Phillips JK. Chlamydial and gonococcal infections: screening, diagnosis, and treatment. Am Fam Physician. 2022;105(4):388-396.
18. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 24th ed. Hudson, OH: Lexicomp; 2018.
20. Centers for Disease Control and Prevention. About Syphilis. Available at https://www.cdc.gov/syphilis/about. Last accessed September 12, 2024.
21. Singh PV, Ranjit R. Atypical oral manifestations in secondary syphilis. Indian J Dent Res. 2013;24(1):142-144.
22. Sanchez MR. Syphilis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (eds). Fitzpatrick's Dermatology in General Medicine. 8th ed. New York, NY: McGraw Hill; 2012.
23. Ficarra G, Carlos R. Syphilis: the renaissance of an old disease with oral implications. Head Neck Pathol. 2009;3(3):195-206.
24. Smith MH, Vargo RJ, Bilodeau EA, et al. Oral manifestations of syphilis: a review of the clinical and histopathologic characteristics of a reemerging entity with report of 19 new cases. Head Neck Pathol. 2021;15(3):787-795.
25. Cohen SE, Klausner JD, Engelman J, Philip S. Syphilis in the modern era: an update for physicians. Infect Dis Clin North Am. 2013;27(4):705-722.
26. Pessoa L, Galvão V. Clinical aspects of congenital syphilis with Hutchinson's triad. BMJ Case Rep. 2011;12:1-3.
27. Hillson S, Grigson C, Bond S. Dental defects of congenital syphilis. Am J Phys Anthopol. 1998;107(1):25-40.
28. Gargano J, Meites E, Watson M, Unger E, Markowitz L, Centers for Disease Control and Prevention. Manual for Surveillance of Vaccine-Preventable Diseases. Chapter 5: Human Papillomavirus (HPV). Available at https://www.cdc.gov/vaccines/pubs/surv-manual/chpt05-hpv.html. Last accessed September 12, 2024.
29. Centers for Disease Control and Prevention. About HPV. Available at https://www.cdc.gov/hpv/about/ Last accessed September 12, 2024.
30. Syrjänen S. Human papillomavirus infections and oral tumors. Med Microbiol Immunol. 2003;192(3):123-128.
31. Schlecht NF, Masika M, Diaz A, et al. Risk of oral human papillomavirus infection among sexually active female adolescents receiving the quadrivalent vaccine. JAMA Netw Open. 2019;2(10):e1914031.
32. Lukes SM, Meneses MB. The dental hygienist's role in HPV recognition. Dimens Dent Hyg. 2010;8(6):72.75-77.
33. University of Washington. Oral Pathology Case of the Month: Condyloma Acuminatum. Available at https://dental.washington.edu/oral-pathology/case-of-the-month-archives/com-jan-2011-diagnosis. Last accessed September 12, 2024.
34. Jackson JL, Muhammad A, Longwe E, Childers Ester LB, Mody V. Condyloma acuminatum: an opportunistic infection found in the oral cavity. New York Medical Journal. 2010;5(2).
35. Weiss A, Dym H. Oral Lesions Caused by the Human Papillomavirus. Available at https://www.clinicaladvisor.com/features/oral-lesions-caused-by-human-papillomavirus. Last accessed September 4, 2024.
36. Fazel N, Wilczynski S, Lowe L, Su LD. Clinical, histopathologic and molecular aspects of cutaneous human papillomavirus infections. Dermatol Clin. 1999;17(3):521-536.
37. Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of the human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26(1):K1-K16.
38. Patton L, Glick M. The ADA Practical Guide to Patients with Medical Conditions. 2nd ed. Chichester: Wiley-Blackwell; 2016.
39. Centers for Disease Control and Prevention. HPV and Oropharyngeal Cancer. Available at https://www.cdc.gov/cancer/hpv/oropharyngeal-cancer.html. Last accessed September 12, 2024.
40. National Cancer Institute. Oropharyngeal Cancer Treatment (Adult). Available at https://www.cancer.gov/types/head-and-neck/hp/adult/oropharyngeal-treatment-pdq. Last accessed September 12, 2024.
41. Waldboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19.
42. Centers for Disease Control and Prevention. Human Papillomavirus (HPV) Vaccine Safety. Available at https://www.cdc.gov/vaccine-safety/vaccines/hpv.html. Last accessed September 12, 2024.
43. U.S. Food and Drug Administration. Gardasil 9. Available at https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9. Last accessed September 12, 2024.
44. European Society for Medical Oncology. FDA Approves Gardasil 9 for Prevention of Certain Cancers Caused by Five Additional Types of HPV. Available at https://www.esmo.org/oncology-news/archive/fda-approves-gardasil-9-for-prevention-of-certain-cancers-caused-by-five-additional-types-of-hpv. Last accessed September 12, 2024.
45. Herrero R, Quint W, Hildesheim A, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013;8(7):e68329.
46. Ozden B, Gunduz K, Gunhan O, Ozden FO. A case report of focal epithelial hyperplasia (Heck's disease) with PCR detection of human papillomavirus. J Maxillofac Oral Surg. 2011;10(4):357-360.
47. Centers for Disease Control and Prevention. About Epstein-Barr Virus (EBV). Available at https://www.cdc.gov/epstein-barr/about/index.html. Last accessed September 12, 2024.
48. Little JW, Falace DA, Miller CS, Rhodus NL. Little and Falace's Dental Management of the Medically Compromised Patient. 8th ed. St. Louis, MO: Elsevier/Mosby; 2013.
50. Shetty K. Epstein-Barr Virus (EBV) Infectious Mononucleosis (Mono) Workup. Available at https://emedicine.medscape.com/article/222040-workup. Last accessed September 12, 2024.
51. Ónodi-Nagy K, Kinyó Á, Meszes A, Garaczi E, Kemény L, Bata-Csörgő Z. Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitization. Allergy Asthma Clin Immunol. 2015;11(1):1.
52. Cade JE. Hairy Leukoplakia. Available at https://emedicine.medscape.com/article/279269-overview. Last accessed September 12, 2024.
53. Centers for Disease Control and Prevention. About Genital Herpes. Available at https://www.cdc.gov/herpes/about. Last accessed September 12, 2024.
54. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006; 296(8):964-973.
55. Johns Hopkins Medicine. Genital Herpes. Available at https://www.hopkinsmedicine.org/health/conditions-and-diseases/herpes-hsv1-and-hsv2/genital-herpes. Last accessed September 12, 2024.
56. Centers for Disease Control and Prevention. About Chlamydia. Available at https://www.cdc.gov/chlamydia/about/index.html. Last accessed September 12, 2024.
57. Sexually Transmitted Diseases Guide. Chlamydia. Available at https://www.std-gov.org/stds/chlamydia.htm. Last accessed September 12, 2024.
58. Centers for Disease Control and Prevention. HIV in the United States and Dependent Areas. Available at https://www.cdc.gov/hiv-data. Last accessed September 25, 2024.
59. Joyce MP, Kuhar D, Brooks JT. Notes from the field: occupationally acquired HIV infection among health care workers—United States, 1985–2013. MMWR. 2015;63(53):1245-1246.
60. Centers for Disease Control and Prevention. Occupational HIV Transmission and Prevention Among Health Care Workers. Available at https://www.cdc.gov/hiv/workplace/healthcareworkers.html. Last accessed September 16, 2024.
1. World Health Organization. WHO Guidelines for the Treatment of Neisseria gonorrhoeae. Geneva: World Health Organization; 2016. Available at https://www.who.int/publications/i/item/9789241549691. Last accessed September 27, 2024.
2. The U.S. Preventive Services Task Force. Syphilis Infection in Nonpregnant Adults and Adolescents: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-nonpregnant-adults-adolescents-screening. Last accessed September 27, 2024.
3. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. Washington, DC: Department of Health and Human Services; 2024. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-oi/guidelines-adult-adolescent-oi.pdf. Last accessed September 27, 2024.
Mention of commercial products does not indicate endorsement.